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Abstract
Background: An organic extract of the recreational herb khat (Catha edulis Forsk.) triggers cell
death in various leukemia cell lines in vitro. The chemotherapeutics camptothecin, a plant alkaloid
topoisomerase I inhibitor, was tested side-by-side with khat in a panel of acute myeloid leukemia
cell lines to elucidate mechanisms of toxicity.
Results: Khat had a profound effect on MOLM-13 cells inducing mitochondrial damage, chromatin
margination and morphological features of autophagy. The effects of khat on mitochondrial
ultrastructure in MOLM-13 correlated with strongly impaired routine respiration, an effect neither
found in the khat-resistant MV-4-11 cells nor in camptothecin treated cells. Enforced expression
of anti-apoptotic Bcl-2 protein provided protection against camptothecin-induced cell death and
partly against khat toxicity. Khat-induced cell death in MOLM-13 cells included reduced levels of
anti-apoptotic Mcl-1 protein, while both khat and camptothecin induced c-FLIPL cleavage and
procaspase-8 activation.
Conclusion: Khat activated a distinct cell death pathway in sensitive leukemic cells as compared
to camptothecin, involving mitochondrial damage and morphological features of autophagy. This
suggests that khat should be further explored in the search for novel experimental therapeutics.
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In search for novel experimental cancer therapies, we are
examining cellular and molecular effects of an organic
extract of the recreational herb khat [1,2]. Adverse health
effects are associated with habitual khat use, but underly-
ing molecular mechanisms are poorly understood [3]. The
botanical alkaloid camptothecin (CPT) induces apoptosis
through a defined mechanism in cancer cell lines and its
derivatives irinotecan and topotecan are widely used can-
cer therapeutics [4-6].
Acute myeloid leukemia (AML) is an aggressive hemato-
logical malignancy of the myeloid progenitor cells, char-
acterized by a differentiation block and extensive
leukemic cell accumulation in the bone marrow [7]. Ther-
apeutic approaches in AML may be opposed by numerous
genetic alterations, often affecting pathways regulating
apoptosis [8-10]. Identification of novel substances using
alternative cell death pathways or capable of restoring sen-
sitivity to apoptosis is therefore of therapeutic impor-
tance.
Programmed cell death may occur through the mecha-
nisms of apoptosis, necrosis and excessive autophagy,
with the mitochondria playing a central role in its regula-
tion [11,12]. The Bcl-2 family of proteins is involved in
regulation of mitochondria-mediated death by affecting
the stability of the outer mitochondrial membrane. Anti-
apoptotic Bcl-2 is often found over-expressed in AML,
mediating therapeutic resistance and poor survival
[13,14]. Levels of anti-apoptotic Bcl-2 and pro-apoptotic
Bax have been shown to correlate with spontaneous apop-
tosis in AML cells in vitro [10], and the ratio of Bax to Bcl-
2 in patient cells is proposed to predict clinical response
and outcome [8]. An important role is played by the anti-
apoptotic Mcl-1 member of the Bcl-2 protein family, illus-
trated by its ability to block therapeutic targeting of other
Bcl-2-like proteins [15].
Mitochondria participate in cell death induction through
release of apoptogenic proteins to the cytosol and genera-
tion of excess levels of reactive oxygen species (ROS). The
mitochondrial respiratory chain serves as a major source
of cellular ROS and also represents a target for its damag-
ing effects [16].
Programmed cell death may be initiated from within the
cell (e.g. by DNA damage, ROS, hypoxia), through ligand
activation of cell surface death receptors or through a
combination of both. The proteolytic inactive procaspase-
8 homologue cellular FLICE inhibitory protein (c-FLIP) is
an antagonist of receptor-mediated cell death [17,18]. c-
FLIP over-expression confers resistance to receptor-medi-
ated apoptosis in various malignancies [19,20] and down-
regulation of c-FLIP has been shown to sensitize tumor
cells to apoptosis via cell death receptors [21-23].
We have compared khat and CPT side-by-side in selected
human AML cell lines in order to evaluate the cell death
mechanisms involved. Khat-induced cell death was char-
acterized by adverse effects on mitochondrial structure
and function, chromatin margination and morphological
features of autophagy, including Mcl-1 down-regulation,
c-FLIPL cleavage and procaspase-8 activation. In contrast,
CPT-induced apoptosis was characterized by nuclear frag-
mentation and unaffected mitochondrial function.
Results
AML cell lines exhibited different sensitivities to khat and 
CPT
Selected AML cell lines with molecular features represent-
ative of the malignancy (Methods; Table 1) were exposed
to 200 μg/ml khat [1,24], and 0.1 and 1.0 μM CPT for 8
hrs before evaluation of toxic effects. When employing a
viability/proliferation assay based on mitochondrial
activity (WST-1) the monocytic cell lines MOLM-13 and
MOLM-14 and the promyelocytic NB4 cell line were
observed to be most sensitive to khat. The biphenotypic
MV-4-11 cell line was the most resistant, particularly to
khat (Fig. 1A).
A similar variation in khat and CPT sensitivity was
observed when using nuclear morphology to assess cyto-
toxicity (Fig. 1B), although with some differences.
Whereas the WST-1 viability/proliferation assay indicated
that khat-treated MV-4-11 cells possessed 43.5 ± 10.8%
(SEM) viability/proliferation as compared to controls,
this cell line appeared relatively resistant to khat-induced
changes in nuclear morphology (90.4 ± 7.0% (SEM) nor-
mal nuclei as compared to controls). NB4 was approxi-
mately as sensitive to khat as MOLM-13 and -14 based on
the WST-1 assay (6.5 ± 3.9% (SEM) viability/proliferation
Table 1: Endogenous Bcl-2 and Bax protein levels (MFI ± SD); 
selected molecular characteristics.
Cell line: Bcl-2: Bax: Bcl-2/Bax: TP53: FLT3:
MOLM-13 43.4 ± 15.7 12.8 ± 6.1 3.6 ± 0.7 wt ITD
HL-60 83.5 ± 13.3 27.1 ± 3.9 3.1 ± 0.6 del wt
MV-4-11 36.4 ± 10.7 13.0 ± 1.7 2.8 ± 0.5 wt ITD
MOLM-14 26.0 ± 7.7 17.9 ± 6.5 1.5 ± 0.6 wt ITD
NB4 15.6 ± 4.3 22.5 ± 0.9 0.7 ± 0.2 mut wt
Endogenous protein levels of Bcl-2 and Bax were determined by 
intracellular staining with labeled antibodies followed by flow 
cytometric analyses. Semi-quantitative measures of protein levels 
given as mean fluorescence intensity (MFI) were used to calculate the 
Bcl-2/Bax ratios. The results are based on three separate experiments 
performed in triplicates, with error bars representing standard error 
of mean. The genetic status of the prognostic markers TP53 and FLT3 
have been reported by others [25-27].Page 2 of 13
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ate level of sensitivity based on morphology (48.6 ± 7.2%
(SEM) normal nuclei as compared to controls).
Khat and CPT treatment induced distinct ultrastructural 
features
To elucidate the mechanisms underlying khat- and CPT-
induced cell death, the khat- sensitive MOLM-13 cell line
and the partly khat-resistant MV-4-11 cell line were exam-
ined by transmission electron microscopy (TEM; Fig. 2).
The lower CPT dose (0.1 μM) was chosen in this experi-
ment since it caused the same level of toxicity in the two
cell lines (Fig. 1B).
The mitochondria in untreated MV-4-11 cells appeared
smaller, with less defined cristae compared to the mito-
chondria in untreated MOLM-13 cells. The most pro-
found effect of khat observed was damage to the inner
mitochondrial membrane in MOLM-13 cells. The affected
mitochondria contained fewer cristae (1.9 ± 0.9 (SEM)
cristae per mitochondria) compared to mitochondria in
control cells (7.4 ± 1.3), suggesting that the cristae had
been subjected to degradation. Khat treatment appeared
to trigger autophagosome formation in MOLM-13 cells
(Fig. 2, insert). The mitochondrial inner membranes in
CPT-exposed MOLM-13 cells were partly affected (3.7 ±
1.0 (SEM) cristae pr mitochondria), while mitochondria
in MV-4-11 seemed normal. Both khat and CPT caused
involution of the endoplasmic reticulum, aggregation of
ribosomes and reduced numbers of microvilli. MOLM-13
cells in late phases of khat-induced cell death were charac-
terized by extensive cytosolic vacuolization and chroma-
tin margination, while CPT mediated less prominent
vacuolization and induced nuclear fragmentation (data
AML cell lines exhibited different sensitivities to khat and CPTFigure 1
AML cell lines exhibited different sensitivities to khat and CPT. Selected human AML cell lines were exposed to 200 
μg/ml khat, 0.1 μM CPT and 1.0 μM CPT for 8 hrs and evaluated for toxic effects. (A) Effects on cell viability/proliferation 
were assessed using the WST-1 assay. The results were collected by measuring absorbance (450 nm - 620 nm) and are pre-
sented as: [(absorbance treated cells)/(absorbance control cells)] × 100. (B) Effects on nuclear morphology were determined 
following Hoechst staining using epifluorescent microscopy. The results are presented as percentages cells with normal nuclear 
morphology as compared to controls. The difference in khat sensitivity between MOLM-13 and MV-4-11 was statistical signifi-
cant as indicated by the asterisk (p < 0.05). The results in A are based on two separate experiments and the results in B based 
on three separate experiments; all experiments were run in triplicate; the bars represent standard error of mean (SEM).
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changes following khat treatment, supporting the relative
khat-resistance of this cell line. The observations based on
TEM of khat- and CPT-treated MOLM-13 cells were scored
and are summarized in Table 2.
Khat induced impaired mitochondrial respiration in 
MOLM-13 and MV-4-11
Based on the TEM observations and the partly diverging
results from the viability/proliferation WST-1 assay and
the nuclear morphology assay (Fig. 1), we decided to
probe mitochondrial function in MOLM-13 and MV-4-11
in more detail. Mitochondrial routine respiration was
assessed by measurements of cellular oxygen consump-
tion rates after treatment with khat and 0.1 μM CPT. Mito-
chondrial respiration was slightly reduced in both
MOLM-13 and MV-4-11 after 2 hrs of khat treatment, the
effect being more pronounced in MOLM-13 cells (Fig. 3).
After 8 hrs of khat exposure the mitochondrial routine res-
piration was significantly lowered in MOLM-13, consist-
ent with the WST-1 assay (Fig. 1A). In contrast to MOLM-
13, the respiration appeared restored in MV-4-11 after 8
hrs of khat treatment. After 24 hrs, khat-exposed MOLM-
13 cells were no longer viable based on morphological
Khat and CPT induced distinct ultrastructural features in MOLM-13 and MV-4-11Figure 2
Khat and CPT induced distinct ultrastructural features in MOLM-13 and MV-4-11. MOLM-13 and MV-4-11 cells 
were exposed to 200 μg/ml khat and 0.1 μM CPT for 8 hours and prepared for transmission electron microscopy, see Meth-
ods for experimental details. Arrows indicate different ultrastructural features of microvilli and mitochondria. A double-mem-
brane autophagosome is enlarged in the insert. The cells selected for this figure were either apparently unaffected or in early 
phases of cell death. Images of cells in late cell death are not shown.Page 4 of 13
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tory activity. The MV-4-11 cells, however, appeared mor-
phologically normal and mitochondrial respiration in
khat-treated cells was identical to respiration in the con-
trols. CPT treatment for 8 hrs did not inhibit the mito-
chondrial routine respiration in MOLM-13 or MV-4-11
cells, even if inspection of nuclear morphology demon-
strated induction of approximately 50% cell death (Fig.
1B). In general, the observed effects on routine respiratory
rates paralleled those of maximal respiratory rates (data
not shown).
The data indicated that khat treatment caused detrimental
impairment of mitochondrial function in MOLM-13 cells,
whereas the effect was minor and transient in MV-4-11
cells.
Endogenous Bcl-2 levels and Bcl-2/Bax ratios did not 
correlate with cellular khat-sensitivity
Since khat affected mitochondrial structure and function,
we hypothesized a role for the Bcl-2 family of proteins in
khat-sensitivity. Endogenous Bcl-2 and Bax levels were
assessed in the panel of AML cell lines using flow cytome-
try. Repeated measurements (n = 3) of Bcl-2 and Bax
based on mean fluorescence intensity (MFI) were used to
determine semi quantitative protein levels and to calcu-
late Bcl-2/Bax ratios (Table 1).
However, no correlations were found between Bcl-2 and/
or Bax levels and the observed khat- and CPT-sensitivities
(Fig. 1A and 1B). The genetic status of the prognostic fac-
tors TP53, FLT3 and karyotype [25-27] did not determine
cellular responsiveness to khat or CPT. This suggested
other pathways and mechanisms as more important in
determining cell death thresholds.
Bcl-2 over-expression protected against CPT and partly 
against khat-induced death
To determine if khat- and CPT-sensitivity could be modu-
lated by Bcl-2 levels within the same cell line, the rat acute
promyelocytic cell line IPC-81 parental and its clone IPC-
81 Bcl-2 were exposed to the two treatments. The IPC-81
Bcl-2 clone is stably transduced to express a Bcl-2 gene of
human origin and has been reported to be resistant to
pro-apoptotic stimuli [28]. The cell lines were exposed to
200 μg/ml khat and 0.1 μM CPT and toxic effects were
evaluated after 24 hrs using the viability/proliferation
WST-1 assay and examination of nuclear morphology
(Fig. 4A and 4B). The viability/proliferation assay demon-
strated that khat-exposed IPC-81 parental and IPC-81 Bcl-
2 possessed approximately 50% lower viability compared
to untreated controls. In contrast, the toxic effects of CPT
were significantly inhibited in the BCL-2 transduced clone
compared to the parental cell line (Fig. 4A).
Inspection of khat-treated samples revealed that the IPC-
81 parental included apoptotic cells and relatively large
amounts of cell debris, which contrasted with the IPC-81
Bcl-2 clone (Fig. 4B). It was estimated that at least 30% of
the IPC-81 parental cells had died following khat treat-
ment, whereas the Bcl-2 over-expressing clone appeared
approximately resistant. CPT-induced cell death was sig-
nificantly inhibited by Bcl-2 over-expression (Fig. 4C).
To validate the results obtained with the IPC-81 cells, the
human promyelocytic NB4 cell line was transiently trans-
fected with either an empty control plasmid, a GFP-
encoding control plasmid (45% post-transfection viabil-
ity at 24 hrs, transfection efficiency > 40%; Fig. 4D) or a
Bcl-2 encoding plasmid prior to khat exposure. Western
blotting demonstrated an increase in Bcl-2 protein level
by 30% in the Bcl-2 plasmid transfected cells compared to
Table 2: Summary of structural characteristics of MOLM-13
Structural characteristics: control khat CPT
Normal mitochondria + + + + + +(+)
Presence of ER + + + + + + +
Ribosomal clustering - + +
Presence of microvilli + + + + +
Cytosolic vacuolization* + + + + + +
Nuclear margination* - +++ -
Nuclear fragmentation* - + + + +
* scores based on khat/CPT treated cells in late phases of cell death
Based on TEM pictures different structural characteristics of MOLM-
13 cells following khat (200 μg/ml) and CPT (0.1 μM) treatment were 
compared to controls and scored (n = 60).
Mitochondrial respiration was impaired in MOLM-13 while only tempor ry affected in MV-4-11Figur  3
Mitochondrial respiration was impaired in MOLM-13 
while only temporary affected in MV-4-11. MOLM-13 
and MV-4-11 cells were exposed to 200 μg/ml khat and 0.1 
μM CPT for the indicated hours and O2 consumption meas-
ured by high-resolution respirometry. Cellular O2 was calcu-
lated from the recorded data as the time derivative of the 
oxygen content in the chamber, and results presented as per-
centages O2consumption per cell in treated cells as com-
pared to untreated controls. This figure shows the results 
from one typical experiment.
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Over-expression of Bcl-2 provided protection against CPT while only partly inhibiting khat-induced cell deathFigur  4
Over-expression of Bcl-2 provided protection against CPT while only partly inhibiting khat-induced cell death. 
IPC-81 parental and IPC-81 Bcl-2 rat leukemia cell lines were exposed 200 μg/ml khat and 0.1 μM CPT for 24 hrs and evalu-
ated for toxic effects. (A) Effects on cell viability/proliferation were assessed using the WST-1 assay. The results were col-
lected by measuring absorbance (450 nm - 620 nm) and are presented as: [(absorbance treated cells)/(absorbance control 
cells)] × 100. The figures in the insert demonstrate the different Bcl-2 protein levels in the two IPC-81 cell lines based on 
Western blotting and flow cytometry. The differences in CPT sensitivity between IPC-81 parental and IPC-81 Bcl-2 were sta-
tistical significant as indicated by the asterisk (p < 0.05). (B) The pictures of Hoechst stained IPC-81 parental and IPC-81 Bcl-2 
cells following treatment with khat shows that khat only affected the IPC-81 parental cells. The arrows indicate the presence of 
cell fragmentation. (C) Effects on nuclear morphology were determined following Hoechst staining using epifluorescent micro-
scopy. The results are presented as percentages cells with normal nuclear morphology as compared to controls. The differ-
ences in CPT sensitivity between IPC-81 parental and IPC-81 Bcl-2 were statistical significant (p < 0.05). (D) The NB4 cell line 
was transiently transfected with either an empty vector, a GFP-encoding control plasmid or a Bcl-2 plasmid and exposed to 
khat (200 μg/ml, 6.5 hrs) 24 hrs after transfection. Effects on cell viability/proliferation were assessed using the WST-1 assay 
showing a statistical significant protection against khat in the Bcl-2 transfected cells (p = 0.05).
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Molecular Cancer 2009, 8:101 http://www.molecular-cancer.com/content/8/1/101the control cells (Fig. 4D). The WST-1 viability/prolifera-
tion assay indicated that enforced Bcl-2 expression in NB4
cells provided a modest, but significant, protection
against khat-induced cell death (Fig. 4D). These results
lead us to further examine the role of Bcl-2 family pro-
teins.
Khat induced Mcl-1 reduction and caspase-8 activation in 
MOLM-13 cells
Protein levels of Bcl-2 family members were analyzed by
standard Western blotting techniques following treatment
with khat and 0.1 μM CPT. The experiments and analyses
included the relatively khat-resistant MV-4-11 cell line, in
addition to the khat-sensitive MOLM-13, HL-60 (Fig. 5)
and NB4 cell lines (data not shown).
A significant reduction was observed in anti-apoptotic
Mcl-1 levels in MOLM-13 after 6 hrs of khat treatment (p
< 0.05), whereas Bcl-2 and Bax levels were not signifi-
cantly altered (Fig. 5A and 5B). Both khat and CPT
appeared to mediate cleavage-activation of procaspase-8
in the MOLM-13 cell line (Fig. 5A). Caspase-8 activity in
MOLM-13 was further supported by results obtained with
a Caspase-8 colorimetric kit, where a 1.47 ± 0.11 (SEM)
fold-increase in caspase-8 activity was observed following
khat exposure and a 1.48 ± 0.12 (SEM) fold-increase fol-
lowing CTP treatment, as compared to controls. In con-
trast, neither khat nor CPT was observed to mediate
procaspase-8 activation in MV-4-11 and HL-60 (Fig. 5C).
Attempts to inhibit khat-induced cell death in MOLM-13
and HL-60 were made by treating the cells with a specific
inhibitor of caspase-8; Z-IETD-FMK, prior to khat addi-
tion. However, a significant protective effect could not be
detected from this pre-treatment based on the WST-1
assay and nuclear morphology (results not shown).
Khat and CPT induced c-FLIPL cleavage
A statistical significant decrease (0.41 ± 0.09 (SEM) fold
change as compared to controls after 6 hrs) in c-FLIPL lev-
els was observed in khat-treated MOLM-13 cells (Fig. 5A
and 5D) whereas no significant changes were detected in
MV-4-11 and HL-60. In accordance with previous reports,
c-FLIP appeared to be cleaved by CPT treatment in
MOLM-13, MV-4-11 and HL-60 [20] (Fig. 5A). Attempts
to sensitize the cell lines to khat-induced cell death by
transfection with siRNA against c-FLIP were made, but
increased susceptibility was not demonstrated (results not
shown).
The Western blots of c-FLIP expression in MOLM-13, MV-
4-11 and HL-60 displayed different patterns of protein
bands, and may reflect differential expression of different
c-FLIP isoforms in the cell lines (Fig. 5A) [17,18]. How-
ever, RT-PCR of the c-FLIP isoforms (c-FLIPL, c-FLIPS and
c-FLIPR) indicated that the various cell lines used
expressed all three isoforms [29] (Fig. 5D).
Discussion
The MOLM-13 cell line and the MV-4-11 cell line repre-
sent a monocytic acute myeloid leukemia and acute
biphenotypic leukemia, respectively. The cell lines share
the characteristics of wild type TP53 and Flt3 length muta-
tions/internal tandem duplications (ITDs), representing
molecular characteristics with prognostic value in AML
patients.
When comparing selected AML cell lines, the MOLM-13
cell line was observed to be one of the most khat-sensitive,
whereas MV-4-11 represented the most khat-resistant. The
difference in sensitivity was detected both with nuclear
morphology analyses and with the WST-1 assay (Fig. 1). A
possible explanation for the more accentuated effects dis-
played in the MV4-11 cells by the WST-1 assay (Fig. 1A)
lies in the reliance of the WST-1 assay on enzymatic com-
plex II activity of the mitochondrial respiratory chain [30].
The reduced viability/proliferation indicated by the WST-
1 assay was in agreement with the impaired mitochon-
drial routine respiration initially detected in both MOLM-
13 and MV-4-11 (Fig. 3). In contrast to MOLM-13, MV-4-
11 recovered from the khat-induced mitochondrial
impairment after 8 hrs of khat exposure. CPT exposure did
not significantly affect mitochondrial routine respiration
in neither MOLM-13 nor MV-4-11. This suggested that
khat and CPT caused cell death through different mecha-
nisms.
Complex I and III of the respiratory chain are the main
ROS production sites in the cell [31] and mitochondrial
dysfunction may lead to excessive ROS levels inducing
damage to DNA, proteins and membranes [16]. We previ-
ously reported that khat induced ROS in normal oral
keratinocytes and fibroblasts in vitro [2] and recently that
khat affected mitochondrial inner transmembrane poten-
tial in these primary cells [32]. Another study suggests that
khat and the alkaloid fraction produce oxidative stress in
rats by reducing the levels of free radical scavenging
enzymes and glucose, leading to increased ROS and toxic-
ity [33]. These findings, together with the khat-mediated
mitochondrial damage reported in this study, suggest that
ROS could be involved in khat-mediated toxicity in AML
cell lines. Interestingly, it has been reported that treatment
of leukemic cells with inhibitors of mitochondrial func-
tion lead to increased ROS and sensitization of the cells to
drug-induced apoptosis [34].
Khat-treated MOLM-13 cells in late phases of cell death
displayed extensive vacuolization of the cytoplasm indi-
cating increased autophagy [12]. Untreated MOLM-13
cells contained abundant lysosomes while autophago-Page 7 of 13
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Khat induced c-FLIP cleavage and Mcl-1 attenuation in khat sensitive MOLM-13Figure 5
Khat induced c-FLIP cleavage and Mcl-1 attenuation in khat sensitive MOLM-13. (A) MOLM-13, MV-4-11 and HL-
60 were exposed to 200 μg/ml khat and 0.1 μM CPT for 4 and/or 6 hrs and evaluated for selected protein changes by Western 
blotting techniques. (B) Selected results for MOLM-13 were quantified using the KODAK Image Station 2000R software; the 
values normalized to the actin loading control and fold changes calculated. The asterisk indicates a significant reduction in Mcl-
1 levels (p < 0.05). (C) MOLM-13, MV-4-11 and HL-60 were exposed to 200 μg/ml khat and 0.1 μM CPT for 4 hrs and cas-
pase-8 activity evaluated using a Caspase-8 colorimetric kit. Fold change in enzymatic activity was determined by comparing the 
khat- and CPT-exposed samples to untreated controls. (D) Reverse transcription PCR was used to determine the expression 
of different c-FLIP RNA isoforms in the leukemic cell lines tested. Jurkat and Raji cells were utilized as controls since they are 
known to express the cFLIPS and c-FLIPR isoforms, respectively. β-Actin served as loading control. MOLM-13 was exposed to 
200 μg/ml khat for 2, 4 and 6 hrs and evaluated for c-FLIPL cleavage by Western blotting techniques. The results were quanti-
fied, normalized to the actin loading control and fold changes calculated. The asterisk indicates a significant reduction in c-FLIPL 
levels (p < 0.05).
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ther supporting involvement of the autophagosomal-
lysosomal compartment in khat-induced cell death [35].
It is possible that autophagy is triggered in MOLM-13 as a
consequence of khat-induced mitochondrial damage and
concomitant ATP deprivation.
When investigating whether endogenous Bcl-2 levels
affected khat- and CPT- sensitivities using the IPC-81 cell
lines, Bcl-2 over-expression was observed to protect
against khat-mediated death. As previously reported, CPT-
induced cell death was inhibited by Bcl-2 over-expression
[36,37] (Fig. 4). However, endogenous Bcl-2/Bax ratios
could not be correlated to the different khat- and CPT-sen-
sitivities in the AML cell line panel (Table 1). This sug-
gested other molecular characteristics as more important
determinants for cellular responsiveness to khat and CPT.
Khat treatment induced significant down-regulation of
the anti-apoptotic Mcl-1 protein in MOLM-13 (Fig. 5A
and 5B). Neutralization of Mcl-1 has been indicated to
play a central role when targeting Bcl-2 family members in
apoptosis-induction. Mcl-1 also connects the receptor-
and mitochondria-mediated cell death pathways by
antagonizing the caspase-8 cleavage product tBid, which
may induce mitochondrial cytochrome C release [38,39].
It is possible that khat-mediated procaspase-8 activation
and Mcl-1 down-regulation act in conjunction in cell
death-induction in MOLM-13. Mcl-1 has also been shown
to interact with Beclin-1, a Bcl-2 interacting protein that
promotes autophagy [40]. BH3-only pro-apoptotic pro-
teins have been shown to mediate autophagy by compet-
itively disrupting the binding of Beclin-1 to anti-apoptotic
Bcl-2 proteins [41].
When analyzing components of receptor-mediated cell
death, a significant reduction in c-FLIPL levels was
detected in khat-treated MOLM-13 cells. The reduction
appeared to result from cleavage of this full length iso-
form to the p43-FLIP fragment (Fig. 5A and 5D). Procas-
pase-8 and active caspase-8 have been shown to exhibit
different specificities when catalyzing c-FLIP cleavage
[42]. Khat-induced generation of p43-FLIP indicated the
presence of active caspase-8, suggesting involvement of
death receptor signaling [1]. In agreement with this, pro-
caspase-8 activation was observed to be mediated by both
khat and CPT in the MOLM-13 cell line (Fig. 5A and 5C).
CPT was shown to induce c-FLIPL cleavage in MOLM-13
and cleavage reactions were also indicated in MV-4-11
and HL-60 (Fig. 5A). Reduced c-FLIP expression and
increased susceptibility to death receptor-induced apopto-
sis has been demonstrated for CPT and drugs like cispla-
tin, doxorubicin and trichostatin A [20,43]. Transfection
experiments were performed with siRNA against c-FLIP,
but sensitization to khat-induced cell death was not
observed in MOLM-13, MV-4-11 or HL-60 (results not
shown). c-FLIP down-regulation has been reported to
occur in conjunction with ROS generation [22,44,45],
and ROS has as mentioned been implicated in in vitro and
in vivo studies on khat toxicity [2,33].
Conclusion
We have shown that a botanical khat extract induced cell
death in a subset of AML cell lines, indicating distinct
molecular mechanisms involved as compared to CPT-
induced apoptosis. Khat was shown to target mitochon-
drial structure and function, which may trigger enhanced
autophagy and induce further cellular damage. Future
studies should identify the pro-cell death components in
khat and evaluate the potential of these substances within
experimental cancer therapy.
Methods
Khat (Catha edulis Forsk.) extract preparation and 
analysis
Khat (asili cultivate) samples from the Meru district in
Kenya were transported at 4°C under moist conditions.
The material was extracted within 48 hrs of harvest using
methanol extraction as previously described [1]. The
methanol extract was dried using a rotary evaporator and
the semi solid residue dissolved at a concentration of 0.2
g/ml dimethylsulphoxide (DMSO) (Sigma, St. Louis, MO,
USA) for storage in -80°C. The DMSO stock solution was
diluted 1:10 in cell culture medium with 10% fetal bovine
serum (FBS) and antibiotics. The dilution step resulted in
precipitate formation [1]. In this study the precipitate was
removed by centrifugation (10 000 × gav., 15 min, 4°C),
and the supernatant was further diluted 1:100 in cell cul-
ture medium giving a final dilution of 1:1000, corre-
sponding to 200 μg/ml based on the DMSO stock
concentration. The DMSO concentration in experimental
cell cultures was 0.1% and control cells were added an
equivalent amount of DMSO. Cells were exposed to the
khat extract for different periods of time (4, 6, 8 and 24
hrs) before being analyzed for changes in viability/prolif-
eration, nuclear morphology, mitochondrial respiration
and protein levels.
The concentrations of cathinone, cathine and norephe-
drine in the khat extract were determined using high pres-
sure liquid chromatography and mass spectrometry
(HPLC-MS-MS). The khat extract was diluted 1:100 in
water containing 0.1% formic acid and separated using an
Ace 3 Phenyl column (2.1 × 50 mm, 3 μm) (Advanced
Chromatography Technologies). The alkaloids were
eluted with a gradient of methanol and 0.1% formic acid
with 5 mM ammonium formiate in H2O. The MS analysis
was carried out using positive electrospray ionization on
an Agilent G6410A QQQ Mass Spectrometer (AgilentPage 9 of 13
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centrations were as follows: S-(-)-cathinone: 2.5, (1S, 2S)-
(-)-norpseudoephedrine (cathine) 3.0 and (1R, 2S)-(-)-
norephedrine: 0.3; all values presented as mg/ml.
Cultivation and characteristics of AML cell lines
The biphenotypic cell line MV-4-11 was purchased from
ATCC (American Type Culture Collection, Manassas, VA,
USA) and cultured in IMDM (BioWhittaker, Cambrex Bio
Science, Verviers, Belgium) with 10% FBS, 2 mM L-
glutamine, 100 IU/ml penicillin and 100 μg/ml strepto-
mycin (Gibco, Grand Island, NY, USA). The promyelo-
cytic HL-60 was purchased from DSMZ (Deutsche
Sammlung von Mikroorganismen und Zellkulturen,
Braunschweig, Germany); the monocytic MOLM-13 and
MOLM-14 were a generous gift from Dr. Kunzo Orita,
Okayama, Japan; the promyelocytic NB4 was a generous
gift from Dr. Michel Lanotte, Hôpital St. Louis, Paris,
France; all cell lines were cultured in RPMI 1640 (Sigma,
St. Louis, MO, USA) with 10% FBS, L-glutamine and anti-
biotics. The IPC-81 cell lines, also a gift from Dr. Michel
Lanotte, Paris, were cultured in RPMI 1640 (Sigma, St.
Louis, MO, USA) with 10% horse serum, L-glutamine and
antibiotics. Jurkat and Raji cell lines were cultivated in
RPMI 1640 with 10% FBS, L-glutamine and antibiotics.
The Jurkat cells were purchased from ATCC while the Raji
cells were a kind gift from Torbjørn Hansen, The Gade
Institute, University of Bergen, Norway. Cells were rou-
tinely screened for mycoplasma and maintained in a
humidified atmosphere at 37°C with 5% CO2. The cell
lines were seeded at a concentration of 200 000 cells/ml
when used in experiments. Molecular characteristics of
the cell lines are shown in Table 1.
Cell viability/proliferation assay
Viability/proliferation was determined using the Cell Pro-
liferation Reagent WST-1 (Roche Applied Science) accord-
ing to the manufacturer's protocol. Aliquots (90 μl) of
cells (200 000 cells/ml) were added 10 μl WST-1 four
hours after initiation of the experiments. The cells were
treated for 4 more hours and the results collected using a
Tecan Infinite 200 microplate reader and Magellan soft-
ware (version 6) (Tecan Trading AG, Switzerland). The
results are presented as percentage viability/proliferation
of treated cells relative to controls, using the formula:
[(abs. treated cells)/(abs. control cells)] × 100.
Cell death determination based on nuclear morphology
Cell death was determined as described by Gjertsen et al.
[46] by microscopy of cell aliquots (50 μl) fixed in nutri-
ent media containing 4% formaldehyde with 10 μg/ml of
the DNA-specific fluorochrome, bisbenzimide (Hoechst
33342; Calbiochem, San Diego, CA, USA). Nuclear mor-
phology was examined under epifluorescent microscopy
using a Leica IRB inverse microscope.
Intracellular staining and flow cytometry
Intracellular staining of Bcl-2 and Bax with conjugated
antibodies was performed according to procedures previ-
ously described [47]. Samples of 3 × 106 cells were washed
with ice cold NaCl (9 mg/ml), fixed with 2% paraformal-
dehyde (Sigma-Aldrich, St. Louis, MO, USA) and permea-
bilized with cold methanol. Cells were washed with 1%
bovine serum albumine (BSA) in phosphate buffered
saline (PBS) and antibodies added. Cells were labeled
with FITC-conjugated hamster anti-human Bcl-2 (6C8),
isotype control (Ha4/8) (both from FITC-conjugated Bcl-
2 Antibody Reagent Set, BD Pharmingen, San Diego, CA,
USA) or PE-labeled anti-human Bax (clone 2D2, Santa
Cruz Biotechnology, CA, USA). The samples were washed
and resuspended in 1% BSA in PBS and subjected to flow
cytometry.
Flow cytometric data were collected on a FACS Calibur
(Becton Dickinson Immunocytometry Systems, San Jose,
CA, USA) and analyzed using FlowJo software (Tree Star,
Inc., Ashland, OR, USA). A semi-quantitative measure of
protein levels, given as mean fluorescence intensity (MFI),
was calculated by subtracting the unspecific binding of the
isotype control from the bound conjugated antibody.
Transmission electron microscopy
Cells were fixed in 0.1 M Na-cacodylate buffer, pH 7.4
containing 2% glutaraldehyde. Samples were rinsed with
buffer and post-fixed in 1% osmium tetroxide. The speci-
mens were dehydrated using graded ethanol and embed-
ded in epoxy resin, and ultra-thin sections double stained
with uranyl acetate and lead citrate [48]. Specimens were
examined with electron microscope (JEOL 1230, Jeol Ltd.,
Tokyo, Japan) and the micrographs processed using an
AGFA Arcus II scanner and Adobe Photoshop 7.0.1 soft-
ware.
Oxygen consumption rates
O2 consumption was determined by high-resolution
respirometry using an Oroboros Oxygraph-2k instrument
(OROBOROS® INSTRUMENTS GmbH, Innsbruck, Aus-
tria). Cells were seeded at a total of 4 × 106 cells and har-
vested after different khat and CPT treatments. The cells
were spun down at 1000 rpm for 4 minutes and resus-
pended in MIR05 buffer (Oroboros lab). The respiration
experiments were conducted at 37°C in MIR05 buffer. A
standard protocol using malate (2 mM), glutamate (10
mM), oligomycin (2 μg/ml), FCCP (0.45 μM), succinate
(10 mM), digitonin (3.68 μM), rotenone (0.5 μM) and
antimycin A (2.5 μM) was used for each measurement.
Cellular O2 was calculated from the recorded data as the
time derivative of the oxygen content in the chamber, O2
concentrations were calculated using DatLab software
(Oroboros Instruments).Page 10 of 13
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Plasmids (5 μg) were introduced into 2 × 106 NB4 cells
using the Cell Line Nucleofector™ Kit V from Amaxa
(Amaxa GmbH, Cologne, Germany) and the Amaxa
Nucleofector™ Device. The bill neo control plasmid and
the bill neo Bcl-2 expression plasmid were generous gifts
from Dr. Timothy J. McDonnell, M.D. Anderson Cancer
Center, Houston, USA [49]. The transfected cells were
challenged with khat and CPT 24 hrs after transfection.
Toxic effects mediated by khat/CPT were evaluated using
the WST-1 assay and nuclear morphology.
Different concentrations (10 nM, 50 nM and 100 nM) of
Silencer® Select siRNA against c-FLIP and control siRNA
(Ambion Inc., Applied Biosystems Inc., Foster City, CA,
USA) were transfected into MOLM-13, HL-60 and MV-4-
11 cells using the optimized protocols found at http://
www.lonzabio.com. The transfected cells were exposed to
khat 24 hrs after transfection and toxicity evaluated using
the WST-1 assay and nuclear morphology.
Western blotting
Cells (4 × 106 pr experimental condition) were washed
with ice cold NaCl (9 mg/ml) and subjected to gel electro-
phoresis (12.5% gels) and Western blotting as previously
described [50]. The membranes were probed with anti-
bodies against Bad (610391) from BD Biosciences (Fran-
klin Lakes, NJ, USA) and procaspase-8 (sc-7890), c-FLIPS/
L (sc-5276), Bcl-2 (sc-783), Bax (sc-20067), Mcl-1 (sc-
12756), Noxa (sc-30209); all purchased from Santa Cruz
Biotechnology, CA, USA. Anti-beta-actin (mAbcam no.
8226; Abcam Inc., Cambridge, MA, USA) was used as
loading control. IgG secondary antibodies conjugated to
Horseradish Peroxidase (Jackson ImmunoResearch, West
Grove, PA, USA) were detected by enhanced chemilumi-
nescence (Supersignal® West Pico or Supersignal® West
Femto; Pierce Biotechnology, Rockford, IL, USA) and vis-
ualized/analyzed using a KODAK Image Station 2000R
(Eastman Kodak Company, Rochester, NY, USA).
Caspase-8 colorimetric kit and inhibition
Caspase-8 activation was assessed using the Caspase-8
colorimetric kit from R&D Systems Inc. (Minneapolis,
MN, USA). The protocol provided by the manufacturer
was followed with some adjustments.
Inhibition of caspase-8 activity was attempted by pre-
treating the cells (200 000 cells/ml) with 10-5 M and 10-6
M Z-IETD-FMK (Sigma-Aldrich, St. Louis, MO, USA) for
15 minutes prior to khat addition (200 μg/ml). Toxic
effects were evaluated with the WST-1 assay and nuclear
morphology.
RNA isolation and RT-PCR
Total RNA was isolated from 5 to 10 × 106 cells using the
RNeasy kit (QIAGEN, Hilden, Germany) and cDNA was
synthesized from 1 μg of total mRNA with the Cloned
AMV First-Strand cDNA Synthesis Kit (Invitrogen Ltd.,
Paisley, UK). c-FLIPL, c-FLIPS, and c-FLIPR was amplified
from cDNA using the HotStarTaq PCR kit from Qiagen
with primers as described by Ueffing [29].
Statistical analysis
Fold change data were based on quantification of Western
blots using the KODAK Image Station 2000R software,
and evaluated for statistical significance (p < 0.05) using
Student's t test.
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